SC-10914
SC10914 is a highly potent PARP inhibitor with potent antiproliferative activity against human BRCA-deficient tumor cells. SC10914 shows potent anti-tumor activity in BRCA1/2 mutated tumor models and has better pharmacokinetic characteristics, and may be selected as a clinical candidate for the treatment of BRCA1/2-deficient cancers.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0071 |
| Pricing | 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, inquire |